“More than three-quarters of 732 surveyed executives at provider, payer and pharmaceutical organizations believe secondary use of data from electronic health records will be their organizations’ greatest asset during the next five years.
But respondents also cite multiple barriers to best use of de-identified and aggregated health information. They also cite the necessity of guidelines for the usage of secondary data that is to be shared. New York consulting firm PricewaterhouseCoopers conducted the e-mail survey in June, getting replies from 482 providers, 136 insurers and 114 pharmaceutical/life sciences organizations.”
Article
Joseph Goedert, Information Management Online, 2 October 2009
Report
